Atriobiventricular pacing improves exercise capacity in patients with heart failure and intraventricular conduction delay

Journal of the American College of Cardiology

Volumn 41, Issue 4, 2003, Pages 582-588

  Varma, Chetan ^a   Sharma, Sanjay ^a   Firoozi, Sam ^a   McKenna, William J ^a   Daubert, Jean Claude ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; CARBON DIOXIDE; DIGITOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ANAEROBIC THRESHOLD; ARTICLE; CALCULATION; CARBON DIOXIDE TENSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY SINUS; DISEASE SEVERITY; ELECTROCARDIOGRAM; EXERCISE; FEMALE; HEART ATRIUM PACING; HEART FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PACING; HEART RATE; HEART VENTRICLE PACING; HUMAN; KINESIOTHERAPY; LUNG MINUTE VOLUME; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OXYGEN CONSUMPTION; PHLEBOGRAPHY; POPULATION; PRIORITY JOURNAL; QRS COMPLEX; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FUNCTION; RESPIRATORY QUOTIENT;

EID: 0037454072     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02849-8     Document Type: Article

References (33)

1. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35.
2. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8.
3. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17.
4. Cleland JGF, Swedberg K, Poole Wilson P. Successes and failures of current treatment of heart failure. Lancet 1998;352 Suppl 1:SI19-28.
5. Cazeau S, Ritter P, Bakdach S, et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol 1994;17:1974-9.
6. Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 1999;99:2993-3001.
7. Kass DA, Chen C-H, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999;99:1567-73.
8. Leclercq C, Cazeau S, Le Breton H, et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 1998;32:1825-31.
9. Varma C, O'Callaghan P, Mahon N, et al. The effect of multisite pacing on ventricular coordination. Heart 2002;87:321-7.
10. Daubert JC, Ritter P, Le Breton H, et al. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. Pacing Clin Electrophysiol 1998;21:239-45.
11. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
12. Chua TP, Ponikowski P, Harrington D, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997;29:1585-90.
13. Kleber FX, Vietzke G, Wernecke KD, et al. Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 2000;101:2803-9.
14. Wasserman K, Hansen JE, Sue DY, et al. Principles of Exercise Testing and Interpretation. 3rd ed. Baltimore, MD: Lippincott, Williams and Wilkins, 1999.
15. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986;60:2020-7.
16. Dyspnoea in heart failure. In: Wasserman K, editor. Exercise Gas Exchange in Heart Disease. Armonk, NY: Futura Publishing, 1996:95-107.
17. Guyatt GH, Sullivan MJ, Thompson PJ, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. CMAJ 1985;132:919-23.
18. Lipkin DP, Scriven AJ, Crake T, et al. Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J 1986;292:653-5.
19. Rector RS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure. II. Content, reliability, and validity of a new measure - the Minnesota Living with Heart Failure questionnaire. Heart Fail 1987;3:198-209.
20. Narang R, Swedberg K, Cleland JGF. What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity. Eur Heart J 1996;17:120-34.
21. Ziesche S, Cobb FR, Cohn JN, et al. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Circulation 1993;87 Suppl:VI56-64.
22. Rouleau JL, Pfeffer MA, Stewart DJ, et al. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. Lancet 2000;356:615-20.
23. Riegger GAJ, Bouzo H, Petr P, et al. Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators. Circulation 1999;100:2224-30.
24. Metra M, Giubbini R, Nodari S, et al. Differential effects of beta blockers in patients with heart failure. Circulation 2000;102:546-51.
25. Hamroff G, Katz SD, Mancini D, et al. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. Circulation 1999;99:990-2.
26. Harrington D, Anker SD, Chua TP, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 1997;30:1758-64.
27. Cazeau S, Ritter P, Lazarus A, et al. Multisite pacing for end stage heart failure: early experience. Pacing Clin Electrophysiol 1996;19:1748-57.
28. Nelson GS, Bergcr R, Fetics B, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle branch block. Circulation 2000;102:3053-9.
29. Clark AL, Coats AJ. Chronotropic incompetence in chronic heart failure. Int J Cardiol 1995;49:225-31.
30. Opasich C, Cobelli F, Riccardi G, et al. Does the study of anacrobic metabolism give quantitative information on left ventricular dysfunction during exercise? Eur Heart J 1988;9 Suppl F:17-21.
31. Bittner V, Weiner DH, Yusuf S, et al., for the SOLVD Investigators. Prediction of mortality and morbidity with a six minute walk test in patients with a left ventricular dysfunction. JAMA 1993;270:1702-7.
32. Florea VG, Mareyev VY, Achilov AA, et al. Central and peripheral components of chronic heart failure: determinants of exercise tolerance. Int J Cardiol 1999;70:51-6.
33. Chua TP, Ponikowski PP, Harrington D, et al. Contribution of peripheral chemoreceptors to ventilation and effects of their suppression on exercise tolerance in chronic heart failure. Heart 1996;76:483-9.